Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA authorizes first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism

October 31, 2018Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

FDA authorizes first direct-to-consumer test for detecting genetic variants that may be associated with medication metabolism

Post navigation

← Statement from FDA Commissioner Scott Gottlieb, M.D., on meetings with industry related to the agency’s ongoing policy commitment to firmly address rising epidemic rates in youth e-cigarette use Jeffrey Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health and Janet Woodcock, M.D., director of the FDA’s Center for Drug Evaluation and Research on agency’s warning to consumers about genetic tests that claim to predict patients’ responses to specific medications →
Proudly powered by WordPress